357 related articles for article (PubMed ID: 21263247)
21. Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma.
Jung SM; Kuo TT
Mod Pathol; 2005 Jun; 18(6):788-94. PubMed ID: 15578072
[TBL] [Abstract][Full Text] [Related]
22. Diffuse expression of PAX2 and PAX8 in the cystic epithelium of mixed epithelial stromal tumor, angiomyolipoma with epithelial cysts, and primary renal synovial sarcoma: evidence supporting renal tubular differentiation.
Karafin M; Parwani AV; Netto GJ; Illei PB; Epstein JI; Ladanyi M; Argani P
Am J Surg Pathol; 2011 Sep; 35(9):1264-73. PubMed ID: 21836481
[TBL] [Abstract][Full Text] [Related]
23. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.
Gonzalez-Roibon N; Albadine R; Sharma R; Faraj SF; Illei PB; Argani P; Ertoy D; Allaf ME; Netto GJ
Hum Pathol; 2013 Dec; 44(12):2651-7. PubMed ID: 24071011
[TBL] [Abstract][Full Text] [Related]
24. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
[TBL] [Abstract][Full Text] [Related]
25. PAX2 and PAX8 expression in primary and metastatic müllerian epithelial tumors: a comprehensive comparison.
Ozcan A; Liles N; Coffey D; Shen SS; Truong LD
Am J Surg Pathol; 2011 Dec; 35(12):1837-47. PubMed ID: 21989345
[TBL] [Abstract][Full Text] [Related]
26. Differentiating Intrarenal Ectopic Adrenal Tissue From Renal Cell Carcinoma in the Kidney.
Yousif MQ; Salih ZT; DeYoung BR; Qasem SA
Int J Surg Pathol; 2018 Oct; 26(7):588-592. PubMed ID: 29873281
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic use of PAX8, CAIX, TTF-1, and TGB in metastatic renal cell carcinoma of the thyroid.
Cimino-Mathews A; Sharma R; Netto GJ
Am J Surg Pathol; 2011 May; 35(5):757-61. PubMed ID: 21451364
[TBL] [Abstract][Full Text] [Related]
28. Clear cell renal cell carcinoma (ccRCC) with hemangioblastoma-like features: a previously unreported pattern of ccRCC with possible clinical significance.
Montironi R; Lopez-Beltran A; Cheng L; Galosi AB; Montorsi F; Scarpelli M
Eur Urol; 2014 Nov; 66(5):806-10. PubMed ID: 24821578
[TBL] [Abstract][Full Text] [Related]
29. Significant variation of immunohistochemical marker expression in paired primary and metastatic clear cell renal cell carcinomas.
Pan Z; Grizzle W; Hameed O
Am J Clin Pathol; 2013 Sep; 140(3):410-8. PubMed ID: 23955461
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of paired box genes 8 and 2 expression in epithelium tissues and the related tumors].
Song Y; Huang X; Shen GH; Liu XY; Zhang X
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):424-428. PubMed ID: 28635231
[No Abstract] [Full Text] [Related]
31. L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells.
Doberstein K; Wieland A; Lee SB; Blaheta RA; Wedel S; Moch H; Schraml P; Pfeilschifter J; Kristiansen G; Gutwein P
Carcinogenesis; 2011 Mar; 32(3):262-70. PubMed ID: 21097529
[TBL] [Abstract][Full Text] [Related]
32. MiRNA-9 and MiRNA-200a distinguish hemangioblastomas from metastatic clear cell renal cell carcinomas in the CNS.
Venneti S; Boateng LA; Friedman JR; Baldwin DA; Tobias JW; Judkins AR; Mourelatos Z; Lal P
Brain Pathol; 2012 Jul; 22(4):522-9. PubMed ID: 22082152
[TBL] [Abstract][Full Text] [Related]
33. Specific immunohistochemical pattern of carbonic anhydrase IX is helpful for the diagnosis of CNS hemangioblastoma.
Schaller T; Bode M; Berlis A; Frühwald MC; Lichtmannegger I; Endhardt K; Märkl B
Pathol Res Pract; 2015 Jul; 211(7):513-20. PubMed ID: 25888144
[TBL] [Abstract][Full Text] [Related]
34. Primary hemangioblastoma of the kidney with molecular analyses by next generation sequencing: a case report and review of the literature.
Wang X; Haines GK; Mehrotra M; Houldsworth J; Si Q
Diagn Pathol; 2022 Feb; 17(1):34. PubMed ID: 35220972
[TBL] [Abstract][Full Text] [Related]
35. Hormone receptor immunoreactivity in hemangioblastomas and clear cell renal cell carcinomas.
Brown DF; Dababo MA; Hladik CL; Eagan KP; White CL; Rushing EJ
Mod Pathol; 1998 Jan; 11(1):55-9. PubMed ID: 9556423
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic utility of PAX8 and PAX2 immunohistochemistry in the identification of metastatic Müllerian carcinoma in effusions.
Wiseman W; Michael CW; Roh MH
Diagn Cytopathol; 2011 Sep; 39(9):651-6. PubMed ID: 20949455
[TBL] [Abstract][Full Text] [Related]
37. Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma.
Luu VD; Boysen G; Struckmann K; Casagrande S; von Teichman A; Wild PJ; Sulser T; Schraml P; Moch H
Clin Cancer Res; 2009 May; 15(10):3297-304. PubMed ID: 19401348
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of putative renal cell carcinoma markers PAX-2, PAX-8, and hKIM-1 in germ cell tumors: a tissue microarray study of 100 cases.
Sangoi AR; McKenney JK; Brooks JD; Bonventre JV; Higgins JP
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):451-3. PubMed ID: 22495365
[TBL] [Abstract][Full Text] [Related]
39. Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma.
Ordóñez NG
Mod Pathol; 2013 Aug; 26(8):1132-43. PubMed ID: 23503645
[TBL] [Abstract][Full Text] [Related]
40. Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma.
Chang A; Brimo F; Montgomery EA; Epstein JI
Hum Pathol; 2013 Aug; 44(8):1563-8. PubMed ID: 23453625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
